tasly Premium 3 times times holding the world pharmaceutical industry to introduce xingnaojing injection

Securities Times Network (www.stcn.com) September 24 September 24 evening, tasly (600535) announced that it will contribute 151 million of the purchase of Henan Tiandi Pharmaceutical Co., Ltd. 45% of the equity, through the control of the world drug industry to introduce xingnaojing injection,　　Enrich and supplement the company's cardio-cerebral vascular product line product categories. World pharmaceutical Industry predecessor was established in 1956 Kaifeng Chinese Medicine Pharmaceutical factory, leading products have xingnaojing injection, Qi Qi water, Shaolin bone-setting essence, brain-healthy tablets, Liuwei Dihuang pill, Crown Heart Su-wan and so on.　　Among them, the world Medicine of xingnaojing injection for the state medical insurance category B varieties, in the hospital prescription Chinese Medicine market brain drugs market share ranked second, because of its wide indications and minimal adverse reaction rate and has a huge market prospects. At the same time, tasly is also subject to the Tianjin Joint Venture Marketing Partnership (limited Partnership) ("Collaborative marketing"). 18th, tasly, cooperation marketing and the world pharmaceutical industry 6 natural shareholders signed the "Share transfer agreement", the agreement, tasly and joint marketing total by 6 natural shareholders holding the world Pharmaceutical 60% Equity. Among them, tasly and cooperation marketing respectively by the world pharmaceutical industry 45% and 15% Equity, the price is 151 million yuan and 50.34 million yuan respectively.　　After the transfer of equity, tasly will hold the world pharmaceutical industry. The information also shows that there are 38 existing houses in the world pharmaceutical industry, where the property has been obtained under the law of Housing 26, to do property rights Certificate of the property 12, are all the world's own investment in the construction of pharmaceutical, ownership clear; the existing state-owned land use rights 1 cases, with independent production of machinery and equipment The GMP certificate in the validity period of 2.　　Valid for the duration of the drug registration documents 97. As of April 30, the world pharmaceutical industry total assets of 116 million yuan, net assets of 86.8477 million yuan.　　After the evaluation of the income law, the total equity of the world pharmaceutical industry is 364 million yuan, and the value-added rate is 318.91%. At present, tasly listed varieties and in the research varieties, stroke, first aid medication only injection of Salvia miltiorrhiza polyphenol acid a product. Upon completion of the above acquisition, tasly will carry out basic research on the varieties of the world pharmaceutical industry, continue to devote to the research on the extraction, separation, qualitative and quantitative study of the effective components of Chinese medicine, carry out new preparations and new dosage forms, carry out two development of the products, and use the existing rich products and strong marketing network complement,　　Increase the strength of domestic market development. In addition, after the equity acquisition, the world pharmaceutical industry will be included in the consolidated statement category, can effectively expand the sales scale, increase the company's operating income, enhance the company's profitability.　　2013 1-April, the world pharmaceutical industry main business income of 61.7202 million yuan, net profit of 10.1179 million yuan.　　September 24, Tasly reported 44.07 Yuan, down 0.81%. (Securities Times Network News Center)